No increased risk of cancer near Sellafield or Dounreay in recent years

July 23, 2014

Children, teenagers and young adults living near Sellafield or Dounreay since the 1990s are not at an increased risk of developing cancer according to research published in the British Journal of Cancer today* (Wednesday).

Researchers from the Childhood Cancer Research Group at the University of Oxford and from Newcastle University studied cancer rates between 1963 and 2006 among those who were under 25 and living near Sellafield or Dounreay when diagnosed. No difference was found in cancer incidence from 1991-2006 between those living near these nuclear power plants and the general population. But the study confirmed the raised risks of cancer, particularly leukaemia, already reported for earlier time periods.

Kathryn Bunch, lead author on the study, said: "For many years, there have been concerns over the potential raised cancer risk among people - particularly children - who live near nuclear installations. This study found that children, teenagers and young adults living close to Sellafield and Dounreay are no longer at an increased risk of developing cancer.

"Furthermore, there is no evidence of any increased risk of cancer later in life for those who were born near these power plants."

The numbers of cancers observed around Sellafield and Dounreay were compared with those expected from national cancer registration rates using census derived population estimates.

Overall, leukaemia is the eleventh most common cancer in the UK, but it accounts for around a third of all cancers diagnosed in children.

Dr Julie Sharp, Cancer Research UK's head of health information, said: "There has been a lot of concern that nuclear power stations could increase the risk of cancer, particularly leukaemia. This study is reassuring for anyone who happens to be living near a power plant, as it shows no increased risk among children, teenagers or young adults in recent years."
-end-


Cancer Research UK

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.